Utama › Strok Hemoragik › New York
Kajian klinikal Strok Hemoragik di New York
7 kajian untuk Strok Hemoragik sedang mencari peserta di lokasi di New York.
Bandar di New York
Teks kajian rasmi (Bahasa Inggeris)
The Use of p48/64 MW HPC Flow Modulation Device in the Treatment of Wide-necked Intracranial Aneurysms
- UBNS, Buffalo
- North Shore University Hospital - Northwell Health, Manhasset
- NYU Langone Health, New York
- dan 2 lagi
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 9 Sep 2026 · NCT07143019Vision Loss Impact on Navigation in Virtual Reality
- University of Rochester, Rochester
Mengambil pesertaSukarelawan sihat dialu-alukan
Umur 21 hingga 75 · Semua jantina · Dikemas kini 25 Ogo 2026 · NCT06047717Rapid Evacuation and Access of Cerebral Hemorrhage Trial
- Albany Medical Center, Albany
- SUNY Upstate Medical University, Syracuse
- Montefiore Medical Center/Albert Einstein School of Medicine, The Bronx
Mengambil peserta
Umur 18 hingga 70 · Semua jantina · Dikemas kini 14 Ogo 2026 · NCT06870812Diagnostic Performance Study of the EMVision Emu™ Brain Scanner in the Detection of Intracranial Hemorrhage in Suspected Stroke Patients
- Mount Sinai West, New York
- Mount Sinai Health System, New York
Mengambil pesertaKajian pemerhatian
Umur 22 ke atas · Semua jantina · Dikemas kini 27 Jul 2026 · NCT06999122Genetic and Environmental Risk Factors for Hemorrhagic Stroke
- Columbia University, New York
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Jul 2026 · NCT00682695Hospital Implementation of a Stroke Protocol for Emergency Evaluation and Disposition
- New York Presbyterian - Weill Cornell Hospital, New York
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 20 Mei 2026 · NCT06094478Minocycline in Stroke Study at Maimonides
- Maimonides Medical Center, Brooklyn
Mengambil pesertaFasa 2/3
Umur 18 ke atas · Semua jantina · Dikemas kini 19 Mac 2026 · NCT07237048Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.